Opportunity Information: Apply for PA 20 028
Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18) is a discretionary grant opportunity from the Agency for Health Care Research and Quality (AHRQ) focused on investigator-initiated research that improves medication safety. The core aim is to support practical, evidence-based strategies, tools, and interventions that reduce medication-related harm while also encouraging more standardized and optimized medication-use practices and behaviors across health care settings. In other words, the opportunity is not limited to studying errors or adverse drug events in isolation; it is designed to fund work that produces implementable improvements that can be adopted and sustained in real-world care.
This program sits within the health funding activity category and is cataloged under CFDA 93.226. The funding mechanism is an R18 grant, which typically aligns with research and demonstration projects that emphasize applied research, implementation, and evaluation of interventions, often with a strong focus on generating actionable findings for health systems, clinicians, and patients. Projects proposed under this opportunity would be expected to go beyond describing a problem by developing, testing, refining, or evaluating concrete improvement approaches, such as system-level safeguards, workflow redesigns, clinical decision support, patient-centered tools, training approaches, or measurement and feedback methods that can reduce risks tied to prescribing, dispensing, administration, monitoring, and transitions of care.
Eligibility is broad within the United States and includes many common applicant types: state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities and Indian housing authorities; and nonprofit organizations both with and without 501(c)(3) status (as long as they are not institutions of higher education in the categories specified). The opportunity also lists an "Others" category, indicating additional U.S.-based organizational types may be eligible depending on AHRQ and federal grant rules. A key restriction is that non-U.S. entities are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible. In practice, that means the applicant organization and the work supported by the grant must be U.S.-based.
The funding opportunity number is PA 20 028, with an original closing date of January 26, 2023, and a creation date of October 10, 2019. The source information provided does not specify an award ceiling or the expected number of awards, suggesting applicants would need to consult the full notice for budget limits, project period details, and other administrative requirements. Overall, the opportunity is intended for U.S. organizations capable of conducting applied medication safety research that produces tested improvement strategies and usable tools, with an emphasis on preventing harm and promoting consistent, high-quality medication practices.Apply for PA 20 028
- The Agency for Health Care Research and Quality in the health sector is offering a public funding opportunity titled "Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.226.
- This funding opportunity was created on 2019-10-10.
- Applicants must submit their applications by 2023-01-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18).
Which federal agency is offering this grant?
This is a discretionary grant opportunity from the Agency for Health Care Research and Quality (AHRQ).
What is the main goal of this funding opportunity?
The core aim is to support investigator-initiated research that improves medication safety by developing and advancing practical, evidence-based strategies, tools, and interventions that reduce medication-related harm and promote more standardized and optimized medication-use practices across health care settings.
Is this opportunity only for studying medication errors or adverse drug events?
No. The opportunity is not limited to studying errors or adverse drug events in isolation. It is designed to fund work that produces implementable improvements that can be adopted and sustained in real-world care.
What type of grant mechanism is this?
This opportunity uses the R18 funding mechanism. Based on the description provided, R18 grants typically align with research and demonstration projects emphasizing applied research, implementation, and evaluation of interventions, with a focus on producing actionable findings for health systems, clinicians, and patients.
What kinds of projects does this opportunity support?
Projects are expected to go beyond describing a problem and instead develop, test, refine, or evaluate concrete improvement approaches that can reduce medication-related risk.
What kinds of strategies or tools are examples of what could be supported?
The opportunity description lists examples such as:
- System-level safeguards
- Workflow redesigns
- Clinical decision support
- Patient-centered tools
- Training approaches
- Measurement and feedback methods
Which parts of the medication-use process are in scope?
The opportunity highlights reducing risks tied to prescribing, dispensing, administration, monitoring, and transitions of care.
What does the program mean by "standardized and optimized medication-use practices"?
Based on the provided description, the program encourages improvement work that helps drive more consistent, high-quality medication-use practices and behaviors across health care settings, not just isolated fixes for single events.
What is the CFDA number for this program?
The program is cataloged under CFDA 93.226.
What is the funding opportunity number?
The funding opportunity number is PA 20 028.
When was this opportunity created?
The creation date listed is October 10, 2019.
What was the original closing date listed for this opportunity?
The original closing date provided is January 26, 2023.
Who is eligible to apply?
Eligibility is broad within the United States and includes the following applicant types (as listed):
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Federally recognized Native American tribal governments
- Other tribal organizations
- Public housing authorities
- Indian housing authorities
- Nonprofit organizations with 501(c)(3) status (with the noted limitation in the description)
- Nonprofit organizations without 501(c)(3) status (with the noted limitation in the description)
- Others (additional U.S.-based organizational types may be eligible depending on AHRQ and federal grant rules)
Are non-U.S. organizations eligible to apply?
No. The description states that non-U.S. entities are not eligible to apply.
Can a U.S. organization apply if part of the project will be conducted by a non-U.S. component of that organization?
No. The description states that non-U.S. components of U.S. organizations are also not eligible. In practice, this means the applicant organization and the work supported by the grant must be U.S.-based.
Does the information provided include the maximum award amount (award ceiling)?
No. The source information provided does not specify an award ceiling.
Does the information provided include the expected number of awards?
No. The source information provided does not specify the expected number of awards.
Where would an applicant look for budget limits and project period details?
Because the summary provided does not include budget limits, project period details, or other administrative requirements, applicants would need to consult the full notice for those specifics.
What is the overall focus or theme of the funded work?
Overall, the opportunity is intended for U.S. organizations capable of conducting applied medication safety research that produces tested improvement strategies and usable tools, with an emphasis on preventing harm and promoting consistent, high-quality medication practices that can be sustained in real-world care.
Browse more opportunities from the same category: Health
Next opportunity: Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
Previous opportunity: MEDIA SUSTAINABILITY PROGRAM
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 20 028
Applicants also applied for:
Applicants who have applied for this opportunity (PA 20 028) also looked into and applied for these:
| Funding Opportunity |
|---|
| Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed) Apply for PAR 20 029 Funding Number: PAR 20 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) Apply for RFA AI 19 065 Funding Number: RFA AI 19 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 059 Funding Number: RFA AI 19 059 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Aging Research Dissertation Awards to Increase Diversity (R36 Clinical Trial Not Allowed) Apply for PAR 19 394 Funding Number: PAR 19 394 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) Apply for PAR 20 021 Funding Number: PAR 20 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Behavioral and Social Research LEaders in Alzheimers Disease and Its Related Dementias (NIA BSR LEADR) (DP1 - Clinical Trial Not Allowed) Apply for RFA AG 20 033 Funding Number: RFA AG 20 033 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03 - Clinical Trial Optional) Apply for RFA HL 20 029 Funding Number: RFA HL 20 029 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not Allowed) Apply for RFA AG 20 027 Funding Number: RFA AG 20 027 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Ethical Issues in Translational Science Research (R01 Clinical Trial Optional) Apply for RFA TR 20 001 Funding Number: RFA TR 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional) Apply for PAR 20 036 Funding Number: PAR 20 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Support of Competitive Research (SCORE) Research Continuance Award (SC3 - Clinical Trial Not Allowed) Apply for PAR 20 041 Funding Number: PAR 20 041 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed) Apply for RFA NS 20 007 Funding Number: RFA NS 20 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building Population Health Research Capacity in the U.S. Affiliated Pacific Islands (U24 Clinical Trial Not Allowed) Apply for PAR 20 048 Funding Number: PAR 20 048 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed) Apply for PAR 20 049 Funding Number: PAR 20 049 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required) Apply for PAR 20 050 Funding Number: PAR 20 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) Apply for PAR 20 046 Funding Number: PAR 20 046 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed) Apply for PAR 20 045 Funding Number: PAR 20 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Dysregulation and Proximal Risk for Suicide (R21 Clinical Trial Optional) Apply for RFA MH 20 326 Funding Number: RFA MH 20 326 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Leadership Award for Alzheimer's Disease and Related Dementias Research (R35 Clinical Trial Not Allowed) Apply for RFA AG 21 007 Funding Number: RFA AG 21 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Dysregulation and Proximal Risk for Suicide (R01 Clinical Trial Optional) Apply for RFA MH 20 327 Funding Number: RFA MH 20 327 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 20 028", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.